Abstract
Hormonal inducrion of breasr cancer in man has nor been esrablished. There are insubsranrial clues poinring ro rhe hormonal environmenr as one of rhe many facrors relevanr ro rhe genesis of breasr cancer. Since perhaps only one-rhird of human breasr cancers are endocrine-sensirive, ir may be difficulr ro delineare endocrine influences in a subser of rhe popularion of women wirh breasr cancer. Possible hormonal alrer-arions may be produced by generic or environmenral effecrs. For example, rhe sensi-riviry of breasr rissue ro esrrogen concenrrarions may vary for generic reasons, or rhe roral esrrogenic srimulus could be alrered by inrake of planr esrrogens. Minimal changes in esrrogen secrerion rares, durarion of prolacrin secrerion, and availability of esrrogen ro rhe rissue are physiologic paramerers rhar are difficulr ro quanrify wirhin rhe normal popularion. Yer small changes persisrenr over many years could produce significanr cocarcinogenic effecrs.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Feinleib, M.: Breast cancer and artificial menopause. A cohort study. J. nat. Cancer Inst. 41, 315 (1968).
Muhlbock, O., Boot, L. M.: The mode of action of ovarian hormones in the induction of mammary cancer in mice. Biochem. Pharmacol. 16, 627 (1967).
MacMahon, B., Cole, P., Lin, T. M., Lowe, C. R., Mirra, A. P., Ravnihar, B., Salber, E. J., Valaoras, V. G., Yuasa, S.: Age at first birth and breast cancer risk. Bull. Wld Hlth Org. 43, 209 (1970).
Cole, P., MacMahon, B.: Oestrogen fractions during early reproductive life in the aetiology of breast cancer. Lancet 1969 I, 604.
de Waard, F.: The epidemiology of breast cancer; review and prospects. Inst. J. Cancer 4, 577 (1969).
Huggins, C, Jensen, E. V.: The depression of estrone-induced uterine growth by phenolic estrogens with oxygenated functions at positions 6 or 16; the impeded estrogens. J. exp. Med. 102, 335 (1955).
Lemon, H. M.: Endocrine influences on human mammary cancer. A critique. Cancer (Philad.) 23, 781 (1969).
Lemon, H. M., Wotiz, H. H., Parsons, L., Mozden, P. J.: Reduced estriol excretion in patients with breast cancer prior to endocrine therapy. J. Amer. med. Ass. 1961, 1128 (1966).
MacMahon, B., Cole, P., Brown, J. B., Aoki, K., Lin, T. M., Morgan, R. W., Woo, N. C.: Oestrogen profiles of Asian and North American women. Lancet 1971 II, 900.
Loriaux, D. L., Ruder, H. J., Knab, D. R., Lipsett, M. B.: Estrone sulfate, estrone, estradiol and estriol plasma levels in human pregnancy. J. clin. Endocr., in press.
Pearson, O. H., Molina, A., Butler, T. P., Llerena, L., Nasr, H.: Estrogens and prolactin in mammary cancer. In Estrogen, Target Tissues and Neoplasia. Ed.: T. L. Dao. Chicago: Univ. Chicago Press 1972.
Bulbrook, R. D., Hayward, J. L., Spicer, C. C: Relation between urinary androgen and corticoid excretion and subsequent breast cancer. Lancet 1971 II, 395.
Editor information
Rights and permissions
Copyright information
© 1973 Springer-Verlag Berlin · Heidelberg
About this chapter
Cite this chapter
Lipsett, M.B. (1973). Hormonal Induction of Breast Cancer. In: Griem, M.L., Jensen, E.V., Ultmann, J.E., Wissler, R.W. (eds) Breast Cancer. Recent Results in Cancer Research / Fortschritte der Krebsforschung / Progrès dans les recherches sur le cancer, vol 42. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-85832-1_5
Download citation
DOI: https://doi.org/10.1007/978-3-642-85832-1_5
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-85834-5
Online ISBN: 978-3-642-85832-1
eBook Packages: Springer Book Archive